The News
Catch the latest updates as CTMC drives innovation in cell therapy to accelerate development and manufacturing
to impact patients sooner
Press Releases
CTMC Appoints Amy Hay as Chief Business Officer and Duane Avant as Chief Technical Officer
HOUSTON, TX, February 5, 2025 — CTMC, a joint venture between Resilience and MD Anderson Cancer Center, has appointed Amy Hay as Chief Business...
CTMC and Syenex Launch Partnership to Accelerate Scalability of Cell Therapies
Houston, TX and Chicago, IL - January 8, 2025: CTMC, a joint venture between MD Anderson Cancer Center and Resilience, has entered a partnership...
Obsidian Therapeutics Announces Positive Interim Top-Line Clinical Data for OBX-115 Engineered TIL Cell Therapy in Advanced or Metastatic Melanoma Post-Anti-PD1 Therapy
CAMBRIDGE, Mass., December 12, 2023 – Obsidian Therapeutics, Inc., a clinical-stage biotechnology company pioneering engineered cell and gene...
Recent News
Tying Advanced Biomanufacturing to a Clinic
read the article here: https://www.genengnews.com/topics/bioprocessing/tying-advanced-biomanufacturing-to-a-clinic/
Democratizing Cell Therapy Through Regional Manufacturing | Amy Hay (Part 4/4)
Host Jon Chee sits down with Amy Hay to hear about how CTMC bridges academia and industry to help lean cell therapy teams reach the clinic faster...
Career Reinvention After Leadership Shakeups | Amy Hay (Part 3/4)
Host Jon Chee sits down with Amy Hay to hear about evolution from a longtime leader at MD Anderson Cancer Center to an entrepreneurial consultant...
The Hidden Cost of Big Wins in Healthcare | Amy Hay (Part 2/4)
Host Jon Chee sits down with Amy Hay to hear about how she transformed ground-level patient care experience at MD Anderson into high-impact...
No Margin, No Mission: The Business Truth Healthcare Leaders Must Accept | Amy Hay (Part 1/4)
Host Jon Chee sits down with Amy to hear about her formative years and the experiences that shaped her unique approach to healthcare leadership....
Building a future for curative cell therapies
In a two-part Off Script podcast, CTMC CEO Jason Bock discusses the manufacturing and operational shifts needed to scale autologous cell therapies....
Advanced therapies and technology point to the future for hematological cancers, but access remains a challenge.
Experts from Brazil and around the world participated in debates held at the Einstein venue during the most important global congress in the field....
CTMC maps out plans to democratize cell therapy
by Dr. Phalguni Deswal / Drug & Device World CTMC’s Amy Hay details a partnership model to share knowledge and expand cell therapy access...
BioProcess International: CTMC discusses journey toward democratizing cell therapy
The venture hopes to expand cell therapies in and beyond Latin America after gaining its first international partner, based in Brazil. Millie...